Evie Carchman, MD, FACS

Assistant Professor

  • Division of Colorectal Surgery

carchman@surgery.wisc.edu
Clinic: (608) 242-2800

  • Administrative Assistant: (608) 263-2521

Clinical Science Center
600 Highland Avenue
Madison, WI 53792-7375

Education

  • MD, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA, 2006
  • General Surgery Residency, University of Pittsburgh Medical Center, Pittsburgh, PA, 2013
  • Colon and Rectal Surgery Fellowship, Cleveland Clinic, Cleveland, OH, 2014

Clinical Specialties

Dr. Evie Carchman is a fellowship-trained colon and rectal surgeon. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.

Research Interests

Dr. Carchman’s research interests focus on the pathogenesis and treatment of anal cancer. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.

Recent Publications

  • The Optimal Ileal Pouch: Physiologic Parameters Significantly Correlate with Overall Pouch Function.
    Melvin JC, Harms BA, Heise CP, Leverson GE, Carchman EH
    J. Gastrointest. Surg. 2020 May 04;
    [PubMed ID: 32367282]

  • Advances in the management of rectal cancer.
    Lawson EH, Melvin JC, Geltzeiler CB, Heise CP, Foley EF, King RS, Harms BA, Carchman EH
    Curr Probl Surg 2019 11; 56(11): 100648
    [PubMed ID: 31779779]

  • Anal Intraepithelial Neoplasia Screening With Anal Pap Tests: Follow-up and Corresponding Histology.
    Geltzeiler CB, Son J, Carchman EH, Lawson EH, Harms BA, Striker R, Selvaggi S, Voils CI
    J. Surg. Res. 2019 12; 244: 117-121
    [PubMed ID: 31284140]

  • Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer.
    Rademacher BL, Matkowskyj KA, LaCount ED, Carchman EH
    Eur. J. Cancer Prev. 2019 11; 28(6): 483-491
    [PubMed ID: 30888976]

  • Genetic inhibition of autophagy in a transgenic mouse model of anal cancer.
    Rademacher BL, Meske LM, Matkowskyj KA, Hanlon BM, Carchman EH
    J Carcinog 2018; 17: 3
    [PubMed ID: 30123096]

All Publications on PubMed